Clindamycin Phosphate (Cleocin T)

Trade Name : Cleocin T

Pharmacia and Upjohn Company LLC

SOLUTION

Strength 10 mg/mL

CLINDAMYCIN PHOSPHATE Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Clindamycin Phosphate (Cleocin T) which is also known as Cleocin T and Manufactured by Pharmacia and Upjohn Company LLC. It is available in strength of 10 mg/mL per ml. Read more

Clindamycin Phosphate (Cleocin T) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • For External Use
  • CLEOCIN T Topical Solution and CLEOCIN T Topical Lotion contain clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. CLEOCIN T Topical Gel contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per gram. Each CLEOCIN T Topical Solution pledget applicator contains approximately 1 mL of topical solution.
  • Clindamycin phosphate is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin.
  • The solution contains isopropyl alcohol 50% v/v, propylene glycol, and water.
  • The gel contains allantoin, carbomer 934P, methylparaben, polyethylene glycol 400, propylene glycol, sodium hydroxide, and purified water.
  • The lotion contains cetostearyl alcohol (2.5%); glycerin; glyceryl stearate SE (with potassium monostearate); isostearyl alcohol (2.5%); methylparaben (0.3%); sodium lauroyl sarcosinate; stearic acid; and purified water.
  • The structural formula is represented below:
  • The chemical name for clindamycin phosphate is Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl--4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L--u03b1-D--octopyranoside 2-(dihydrogen phosphate).
  • No data
  • CLEOCIN T Topical Solution, CLEOCIN T Topical Gel and CLEOCIN T Topical Lotion are indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see , and ).
  • CLEOCIN T Topical Solution, CLEOCIN T Topical Gel and CLEOCIN T Topical Lotion are contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, a history of regional enteritis or ulcerative colitis, or a history of antibiotic-associated colitis.
  • Orally and parenterally administered clindamycin has been associated with severe colitis which may result in patient death. Use of the topical formulation of clindamycin results in absorption of the antibiotic from the skin surface. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of topical and systemic clindamycin.
  • Studies indicate a toxin(s) produced by clostridia is one primary cause of antibiotic-associated colitis. The colitis is usually characterized by severe persistent diarrhea and severe abdominal cramps and may be associated with the passage of blood and mucus. Endoscopic examination may reveal pseudomembranous colitis. n- Stool culture for n- Clostridium difficilen- and stool assay for n- C. difficilen- toxin may be helpful diagnostically.
  • When significant diarrhea occurs, the drug should be discontinued. Large bowel endoscopy should be considered to establish a definitive diagnosis in cases of severe diarrhea.
  • Antiperistaltic agents such as opiates and diphenoxylate with atropine may prolong and/or worsen the condition. Vancomycin has been found to be effective in the treatment of antibiotic-associated pseudomembranous colitis produced by . The usual adult dosage is 500 milligrams to 2 grams of vancomycin orally per day in three to four divided doses administered for 7 to 10 days. . If both a resin and vancomycin are to be administered concurrently, it may be advisable to separate the time of administration of each drug.
  • Diarrhea, colitis, and pseudomembranous colitis have been observed to begin up to several weeks following cessation of oral and parenteral therapy with clindamycin.
  • No data
  • In 18 clinical studies of various formulations of CLEOCIN T using placebo vehicle and/or active comparator drugs as controls, patients experienced a number of treatment emergent adverse dermatologic events [see below].
  • Orally and parenterally administered clindamycin has been associated with severe colitis which may end fatally.
  • Cases of diarrhea, bloody diarrhea and colitis (including pseudomembranous colitis) have been reported as adverse reactions in patients treated with oral and parenteral formulations of clindamycin and rarely with topical clindamycin (see ).
  • Abdominal pain, gastrointestinal disturbances, gram-negative folliculitis, eye pain and contact dermatitis have also been reported in association with the use of topical formulations of clindamycin.
  • Topically applied CLEOCIN T can be absorbed in sufficient amounts to produce systemic effects (see ).
  • Apply a thin film of CLEOCIN T Topical Solution, CLEOCIN T Topical Lotion, CLEOCIN T Topical Gel, or use a CLEOCIN T Topical Solution pledget for the application of CLEOCIN T twice daily to affected area. More than one pledget may be used. Each pledget should be used only once and then be discarded.
  • Lotion: Shake well immediately before using.
  • Pledget: Remove pledget from foil just before use. Do not use if the seal is broken. Discard after single use.
  • Keep all liquid dosage forms in containers tightly closed.
  • CLEOCIN T Topical Solution containing clindamycin phosphate equivalent to 10 mg clindamycin per milliliter is available in the following sizes:
  • 30 mL
  • 60 mL
  • Carton of 60 single-use pledget
  • CLEOCIN T Topical Gel containing clindamycin phosphate equivalent to 10 mg clindamycin per gram is available in the following sizes:
  • 60 gram
  • 30 gram
  • CLEOCIN T Topical Lotion containing clindamycin phosphate equivalent to 10 mg clindamycin per milliliter is available in the following size:
  • 60 mL
  • Store at controlled room temperature 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F) [see USP].
  • Protect from freezing.
  • Rx only
  • This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com.
  • LAB-0042-10.0Revised 12/2019
  • Pfizer
  • NDC 0009-3116-01
  • Cleocin T
  • 1%*
  • Solution
  • 30 mL
  • Rx only
  • Pfizer
  • NDC 0009-3116-01
  • Cleocin T
  • 1%*
  • Solution
  • 30 mLn n
  • Pfizer
  • NDC 0009-3116-14
  • Cleocin T
  • 1%*
  • Pledget
  • 1 Pledget
  • Distributed byPharmacia & Upjohn CoDivision of Pfizer Inc, NY, NY 10017MADE IN CHINA
  • Rx only
  • NDC 0009-3116-14
  • Pfizern- Cleocin Tn- 1%*
  • Pledget
  • 60 Pledgetsn n
  • Pfizer NDC 0009-3329-01
  • Cleocin Tn clindamycinphosphatetopical lotion
  • 1%*
  • For topical use only
  • 60 mL Rx only
  • Pfizer NDC 0009-3329-01
  • Cleocin Tn clindamycinphosphatetopical lotion
  • 1%*
  • For topical use only
  • 60 mL Rx only
  • NDC 0009-3331-01
  • 60 gram
  • Rx only
  • Cleocin T
  • For topical use only
  • 1%*
  • Store at controlled room temperature 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F)[see USP]. Protect from freezing.n- DOSAGE AND USE:
  • Pfizern- Distributed byn- Pharmacia & Upjohn Co
  • NDC 0009-3331-01
  • Pfizer
  • Cleocin Tn 1%*
  • clindamycin phosphate topical gel
  • For topical use only
  • 60 gram Rx only
  • NDC 0009-3331-02
  • 30 gram
  • Rx only
  • Cleocin T
  • For topical use only
  • 1%*
  • Store at controlled room temperature 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F)[see USP]. Protect from freezing.n- DOSAGE AND USE:
  • Pfizern- Distributed byn- Pharmacia & Upjohn Co
  • NDC 0009-3331-02
  • Pfizern- Cleocin Tn- 1%*
  • For topical use only
  • 30 gramn n

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.